Adaptive molecular convergence more common than previously thought
Peer-Reviewed Publication
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 3-Nov-2026 00:15 ET (3-Nov-2026 05:15 GMT/UTC)
First-in-class targeted therapy shows promise against hard-to-treat cancers
Tile-based radiation therapy dramatically reduced recurrence of brain metastases
Targeting individual metastases in oligometastatic breast cancer did not improve survival
Personalized guidance boosts family genetic testing for hereditary cancers
AI tool uncovers signals that either attract immune cells to tumors or keep them out
Mass General Brigham and Harvard Medical School researchers analyzed more than 270 million queries from nearly 1 million clinicians using the AI platform OpenEvidence, finding widespread adoption and showing that clinicians often use AI to support treatment decisions, rather than diagnosis, and that clinicians frequently sought information beyond their own specialty.
Chemical predictions can help prevent unwanted medication reactions or improve efficacy of industrial processes, among other applications, but predicting how chemicals interact can be costly and time-consuming — especially as how chemicals may react in one environment may behave differently in another. A novel experimental modeling approach may help simplify the process by not only increasing the number of chemical predictions, but also the transferability of such foresight.
Infection with human papillomavirus (HPV) is extremely common and, in the vast majority of cases, clears up on its own. However, in some people, it persists and can develop into precancerous lesions or even cancer. How can these high-risk situations be identified at an early stage?